CVS Health Corporation (CVS)
Total Valuation
CVS Health has a market cap or net worth of $100.05 billion. The enterprise value is $167.98 billion.
Market Cap | 100.05B |
Enterprise Value | 167.98B |
Important Dates
The next estimated earnings date is Wednesday, May 1, 2024, before market open.
Earnings Date | May 1, 2024 |
Ex-Dividend Date | Apr 19, 2024 |
Share Statistics
CVS Health has 1.26 billion shares outstanding. The number of shares has decreased by -2.49% in one year.
Shares Outstanding | 1.26B |
Shares Change (YoY) | -2.49% |
Shares Change (QoQ) | +0.23% |
Owned by Insiders (%) | 0.15% |
Owned by Institutions (%) | 83.10% |
Float | 1.25B |
Valuation Ratios
The trailing PE ratio is 12.42 and the forward PE ratio is 9.59. CVS Health's PEG ratio is 1.15.
PE Ratio | 12.42 |
Forward PE | 9.59 |
PS Ratio | 0.28 |
Forward PS | 0.27 |
PB Ratio | 1.31 |
P/FCF Ratio | 9.63 |
PEG Ratio | 1.15 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.17, with an EV/FCF ratio of 16.16.
EV / Earnings | 20.13 |
EV / Sales | 0.47 |
EV / EBITDA | 12.17 |
EV / EBIT | 12.17 |
EV / FCF | 16.16 |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of 1.04.
Current Ratio | 0.86 |
Quick Ratio | 0.59 |
Debt / Equity | 1.04 |
Debt / EBITDA | 5.75 |
Debt / FCF | 7.64 |
Interest Coverage | 5.19 |
Financial Efficiency
Return on equity (ROE) is 11.30% and return on invested capital (ROIC) is 6.60%.
Return on Equity (ROE) | 11.30% |
Return on Assets (ROA) | 3.40% |
Return on Capital (ROIC) | 6.60% |
Revenue Per Employee | $1.19M |
Profits Per Employee | $27,813 |
Employee Count | 300,000 |
Asset Turnover | 1.45 |
Inventory Turnover | 16.35 |
Taxes
In the past 12 months, CVS Health has paid $2.81 billion in taxes.
Income Tax | 2.81B |
Effective Tax Rate | 25.16% |
Stock Price Statistics
The stock price has increased by +8.62% in the last 52 weeks. The beta is 0.50, so CVS Health's price volatility has been lower than the market average.
Beta (1Y) | 0.50 |
52-Week Price Change | +8.62% |
50-Day Moving Average | 75.71 |
200-Day Moving Average | 72.52 |
Relative Strength Index (RSI) | 67.09 |
Average Volume (30 Days) | 11,210,260 |
Short Selling Information
The latest short interest is 24.17 million, so 1.92% of the outstanding shares have been sold short.
Short Interest | 24.17M |
Short Previous Month | 36.79M |
Short % of Shares Out | 1.92% |
Short % of Float | 1.93% |
Short Ratio (days to cover) | 2.34 |
Income Statement
In the last 12 months, CVS Health had revenue of $357.78 billion and earned $8.34 billion in profits. Earnings per share was $6.47.
Revenue | 357.78B |
Gross Profit | 54.43B |
Operating Income | 13.74B |
Pretax Income | 11.15B |
Net Income | 8.34B |
EBITDA | 13.81B |
EBIT | 13.81B |
Earnings Per Share (EPS) | $6.47 |
Balance Sheet
The company has $11.46 billion in cash and $79.39 billion in debt, giving a net cash position of -$67.93 billion or -$53.98 per share.
Cash & Cash Equivalents | 11.46B |
Total Debt | 79.39B |
Net Cash | -67.93B |
Net Cash Per Share | -$53.98 |
Equity / Book Value | 76.46B |
Book Value Per Share | 60.76 |
Working Capital | -11.33B |
Cash Flow
In the last 12 months, operating cash flow was $13.43 billion and capital expenditures -$3.03 billion, giving a free cash flow of $10.40 billion.
Operating Cash Flow | 13.43B |
Capital Expenditures | -3.03B |
Free Cash Flow | 10.40B |
FCF Per Share | $8.09 |
Margins
Gross margin is 15.21%, with operating and profit margins of 3.84% and 2.33%.
Gross Margin | 15.21% |
Operating Margin | 3.84% |
Pretax Margin | 3.12% |
Profit Margin | 2.33% |
EBITDA Margin | 3.86% |
EBIT Margin | 3.86% |
FCF Margin | 2.91% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 3.33%.
Dividend Per Share | $2.66 |
Dividend Yield | 3.33% |
Dividend Growth (YoY) | 9.96% |
Years of Dividend Growth | 2 |
Payout Ratio | 41.11% |
Buyback Yield | 2.49% |
Shareholder Yield | 5.84% |
Earnings Yield | 8.34% |
FCF Yield | 10.39% |
Analyst Forecast
The average price target for CVS Health is $90.14, which is 12.97% higher than the current price. The consensus rating is "Buy".
Price Target | $90.14 |
Price Target Difference | 12.97% |
Analyst Consensus | Buy |
Analyst Count | 23 |
Revenue Growth Forecast (5Y) | 4.84% |
EPS Growth Forecast (5Y) | 12.61% |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
Last Split Date | Jun 7, 2005 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.25 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.25 |
Piotroski F-Score | 6 |